|
FY2022
12 months to Mar 31, 2022
|
FY2021
12 months to Mar 31, 2021
|
|
|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Loss for the year | ||
| Items not affecting cash | ||
| Amortization of property and equipment | ||
| Amortization of deferred development costs | ||
| Inventory expensed as research and development costs | ||
| Unrealized foreign exchange loss (gain) | ||
| Interest accretion | ||
| Finance income | ||
| Interest and other expense | ||
| Change in fair value of derivative liability | ||
| Loss on disposal of equipment | ||
| Warrant adjustment | ||
| Financing expense | ||
| Gain on dilution of investment in Merit Functional Foods Corporation | ||
| Share of loss in Merit Functional Foods Corporation | ||
| Stock-based compensation expense | ||
| Cash flows from (used in) operations | ||
| Changes in non-cash working capital items | ||
| Amounts receivable | ||
| Inventory | ||
| Prepaid expenses | ||
| Accounts payable and accrued liabilities | ||
| Deferred revenue | ||
| Cash used in operating activities | ||
| Interest received | ||
| Interest paid | ||
| Net cash used in operating activities | ||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||
| Interest received | ||
| Investment in Merit Functional Foods Corporation | ||
| Development costs deferred | ||
| Acquisition of property and equipment | ||
| Cash flows from (used in) investing activities | ||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Issue of capital stock | ||
| Issue costs | ||
| Issue of warrants | ||
| Issue of convertible debentures | ||
| Short-term loan | ||
| Repayment of convertible note | ||
| Repayment of short-term loan | ||
| Lease liability | ||
| Lease payments | ||
| Cash flows from (used in) financing activities | ||
| FOREIGN EXCHANGE (LOSS) GAIN ON CASH AND CASH EQUIVALENTS | ||
| (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | ||
| CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR | ||
| CASH AND CASH EQUIVALENTS - END OF YEAR |
Loading...
